Research and Development GB

Research and Development

Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.  

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.  
Search results for "". Page 1 of 1, Results 1 to 4 of 4
Title Location Country Sort descending
Reset
Lead Medical Specialist, Epilepsy
Lead Medical Specialist, Epilepsy Copenhagen, Danish Capital Region, DK 7 May 2025 0.00 km
Copenhagen, Danish Capital Region, DK Denmark
Student assistant - Quality & Compliance, Global Patient Safety
Student assistant - Quality & Compliance, Global Patient Safety Copenhagen, Danish Capital Region, DK 7 May 2025 0.00 km
Copenhagen, Danish Capital Region, DK Denmark
Business Partner, CMC Biologics
Business Partner, CMC Biologics Copenhagen, Danish Capital Region, DK 7 May 2025 0.00 km
Copenhagen, Danish Capital Region, DK Denmark
Medical Science Liaison, Neurology (Western Canada)
Medical Science Liaison, Neurology (Western Canada) Vancouver, British Columbia, CA 3 May 2025 0.00 km
Vancouver, British Columbia, CA Canada